tiprankstipranks
Nascent Biotech Inc. (NBIO)
OTHER OTC:NBIO
US Market

Nascent Biotech (NBIO) Cash flow

33 Followers

Nascent Biotech Cash Flow

NBIO's free cash flow for Q was $―. For the fiscal year, NBIO's free cash flow was decreased by $-2.20M and operating cash flow was $-341.51K. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 23Mar 22Mar 21Mar 20Mar 19
Operating Cash Flow
$ -1.51M$ -1.79M$ 413.48K$ -772.11K$ -554.33K$ -711.81K
Investing Cash Flow
------
Financing Cash Flow
$ 1.34M$ 1.86M$ -320.00K$ 988.22K$ 426.07K$ 726.29K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 1.66M$ 172.19K$ 94.91K$ 222.54K$ 3.22K$ 131.47K
Income Tax Paid Supplemental Data
----$ 0.00$ 0.00
Interest Paid Supplemental Data
-$ 11.13K$ 30.03K-$ 0.00$ 0.00
Issuance Of Capital Stock
$ 1.44M---$ 225.00K$ 643.00K
Issuance Of Debt
$ -100.00K$ 1.66M$ -320.00K$ 345.00K$ 200.00K-
Repayment Of Debt
-$ -275.00K$ -520.00K---
Free Cash Flow
$ -1.17M$ -1.79M$ 413.48K$ -772.11K$ -554.33K$ -711.81K
Domestic Sales
------
Foreign Sales
------
Currency in USD

Nascent Biotech Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis